{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:50:21Z","timestamp":1776898221760,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Program of Shaanxi Province","award":["Grant Number:2018ZDXM-SF-039"],"award-info":[{"award-number":["Grant Number:2018ZDXM-SF-039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Multiple myeloma (MM) is an incurable hematological malignancy characterized by clonal proliferation of malignant plasma B cells in bone marrow, and its pathogenesis remains unknown. The aim of this study was to determine the role of kinesin family member 22 (KIF22) in MM and elucidate its molecular mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of KIF22 was detected in MM patients based upon the public datasets and clinical samples. Then, in vitro assays were performed to investigate the biological function of KIF22 in MM cell lines, and subcutaneous xenograft models in nude mice were conducted in vivo. Chromatin immunoprecipitation (ChIP) and luciferase reporter assay were used to determine the mechanism of KIF22-mediated regulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results demonstrated that the expression of KIF22 in MM patients was associated with several clinical features, including gender (<jats:italic>P<\/jats:italic>\u2009=\u20090.016), LDH (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), \u03b2<jats:sub>2<\/jats:sub>-MG (<jats:italic>P<\/jats:italic>\u2009=\u20090.003), percentage of tumor cells (BM) (<jats:italic>P<\/jats:italic>\u2009=\u20090.002) and poor prognosis (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Furthermore, changing the expression of KIF22 mainly influenced the cell proliferation in vitro and tumor growth in vivo, and caused G2\/M phase cell cycle dysfunction. Mechanically, KIF22 directly transcriptionally regulated cell division cycle 25C (CDC25C) by binding its promoter and indirectly influenced CDC25C expression by regulating the ERK pathway. KIF22 also regulated CDC25C\/CDK1\/cyclinB1 pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>KIF22 could promote cell proliferation and cell cycle progression by transcriptionally regulating CDC25C and its downstream CDC25C\/CDK1\/cyclinB1 pathway to facilitate MM progression, which might be a potential therapeutic target in MM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05747-w","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:01:55Z","timestamp":1715083315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["KIF22 promotes multiple myeloma progression by regulating the CDC25C\/CDK1\/cyclinB1 pathway"],"prefix":"10.1007","volume":"150","author":[{"given":"Meng","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongzhizi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aili","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"12","key":"5747_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nrc2251","volume":"7","author":"L Antoni","year":"2007","unstructured":"Antoni L, Sodha N, Collins I, Garrett MD (2007) CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? Nat Rev Cancer 7(12):925\u2013936. https:\/\/doi.org\/10.1038\/nrc2251","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"5747_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrc2169","volume":"7","author":"R Boutros","year":"2007","unstructured":"Boutros R, Lobjois V, Ducommun B (2007) CDC25 phosphatases in cancer cells: key players? good targets? Nat Rev Cancer 7(7):495\u2013507. https:\/\/doi.org\/10.1038\/nrc2169","journal-title":"Nat Rev Cancer"},{"issue":"Pt 4","key":"5747_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1242\/jcs.137216","volume":"127","author":"W Bruinsma","year":"2014","unstructured":"Bruinsma W, Macurek L, Freire R, Lindqvist A, Medema RH (2014) Bora and Aurora-A continue to activate Plk1 in mitosis. J Cell Sci 127(Pt 4):801\u2013811. https:\/\/doi.org\/10.1242\/jcs.137216","journal-title":"J Cell Sci"},{"issue":"15","key":"5747_CR4","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1016\/j.febslet.2006.05.047","volume":"580","author":"J Chen","year":"2006","unstructured":"Chen J, Dai G, Wang YQ, Wang S, Pan FY, Xue B et al (2006) Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation. FEBS Lett 580(15):3624\u20133630. https:\/\/doi.org\/10.1016\/j.febslet.2006.05.047","journal-title":"FEBS Lett"},{"issue":"5","key":"5747_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/sj.leu.2404172","volume":"20","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Santana-D\u00e1vila R, Van Wier SA, Ahmann GJ, Jalal SM, Bergsagel PL et al (2006) Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Leukemia 20(5):807\u2013813. https:\/\/doi.org\/10.1038\/sj.leu.2404172","journal-title":"Leukemia"},{"issue":"10","key":"5747_CR6","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/cdd.2015.2","volume":"22","author":"YC Cho","year":"2015","unstructured":"Cho YC, Park JE, Park BC, Kim JH, Jeong DG, Park SG et al (2015) Cell cycle-dependent Cdc25C phosphatase determines cell survival by regulating apoptosis signal-regulating kinase 1. Cell Death Differ 22(10):1605\u20131617. https:\/\/doi.org\/10.1038\/cdd.2015.2","journal-title":"Cell Death Differ"},{"issue":"7","key":"5747_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4161\/cc.5.7.2625","volume":"5","author":"B Eymin","year":"2006","unstructured":"Eymin B, Claverie P, Salon C, Brambilla C, Brambilla E, Gazzeri S (2006) p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation. Cell Cycle 5(7):759\u2013765. https:\/\/doi.org\/10.4161\/cc.5.7.2625","journal-title":"Cell Cycle"},{"key":"5747_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.cellbio.15.1.141","volume":"15","author":"LS Goldstein","year":"1999","unstructured":"Goldstein LS, Philp AV (1999) The road less traveled: emerging principles of kinesin motor utilization. Annu Rev Cell Dev Biol 15:141\u2013183. https:\/\/doi.org\/10.1146\/annurev.cellbio.15.1.141","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"10","key":"5747_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrm2774","volume":"10","author":"N Hirokawa","year":"2009","unstructured":"Hirokawa N, Noda Y, Tanaka Y, Niwa S (2009) Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 10(10):682\u2013696. https:\/\/doi.org\/10.1038\/nrm2774","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"5747_CR10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/cancers12040988","volume":"12","author":"LC Holthof","year":"2020","unstructured":"Holthof LC, Mutis T (2020) Challenges for immunotherapy in multiple myeloma: bone marrow microenvironment-mediated immune suppression and immune resistance. Cancers (basel) 12(4):998. https:\/\/doi.org\/10.3390\/cancers12040988","journal-title":"Cancers (basel)"},{"issue":"9","key":"5747_CR11","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.1002\/jcp.28322","volume":"234","author":"G Li","year":"2019","unstructured":"Li G, Xie ZK, Zhu DS, Guo T, Cai QL, Wang Y (2019) KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation. J Cell Physiol 234(9):16517\u201316525. https:\/\/doi.org\/10.1002\/jcp.28322","journal-title":"J Cell Physiol"},{"key":"5747_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12935-020-01191-1","volume":"20","author":"TF Li","year":"2020","unstructured":"Li TF, Zeng HJ, Shan Z, Ye RY, Cheang TY, Zhang YJ et al (2020a) Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer. Cancer Cell Int 20:123. https:\/\/doi.org\/10.1186\/s12935-020-01191-1","journal-title":"Cancer Cell Int"},{"issue":"5","key":"5747_CR13","first-page":"1614","volume":"12","author":"X Li","year":"2020","unstructured":"Li X, Huang W, Huang W, Wei T, Zhu W, Chen G et al (2020b) Kinesin family members KIF2C\/4A\/10\/11\/14\/18B\/20A\/23 predict poor prognosis and promote cell proliferation in hepatocellular carcinoma. Am J Transl Res 12(5):1614\u20131639","journal-title":"Am J Transl Res"},{"issue":"9","key":"5747_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/15384047.2015.1070980","volume":"16","author":"Y Li","year":"2015","unstructured":"Li Y, Lu W, Chen D, Boohaker RJ, Zhai L, Padmalayam I et al (2015) KIFC1 is a novel potential therapeutic target for breast cancer. Cancer Biol Ther 16(9):1316\u20131322","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"5747_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3892\/ijo.2012.1633","volume":"41","author":"Y Li","year":"2012","unstructured":"Li Y, Zhou W, Wei L, Jin J, Tang K, Li C et al (2012) The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinoma. Int J Oncol 41(6):2139\u20132149. https:\/\/doi.org\/10.3892\/ijo.2012.1633","journal-title":"Int J Oncol"},{"key":"5747_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12935-020-01304-w","volume":"20","author":"K Liu","year":"2020","unstructured":"Liu K, Zheng M, Lu R, Du J, Zhao Q, Li Z et al (2020) The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell Int 20:213. https:\/\/doi.org\/10.1186\/s12935-020-01304-w","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5747_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-019-0706-9","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu W, Liu J, Song Y, Wang X, Zhou M, Wang L et al (2019) Mortality of lymphoma and myeloma in China, 2004\u20132017: an observational study. J Hematol Oncol 12(1):22. https:\/\/doi.org\/10.1186\/s13045-019-0706-9","journal-title":"J Hematol Oncol"},{"issue":"7","key":"5747_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/onc.2017.406","volume":"37","author":"AJ Lucanus","year":"2018","unstructured":"Lucanus AJ, Yip GW (2018) Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics. Oncogene 37(7):833\u2013838. https:\/\/doi.org\/10.1038\/onc.2017.406","journal-title":"Oncogene"},{"issue":"4","key":"5747_CR19","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1091\/mbc.e05-08-0751","volume":"17","author":"SS Margolis","year":"2006","unstructured":"Margolis SS, Perry JA, Weitzel DH, Freel CD, Yoshida M, Haystead TA et al (2006) A role for PP1 in the Cdc2\/Cyclin B-mediated positive feedback activation of Cdc25. Mol Biol Cell 17(4):1779\u20131789. https:\/\/doi.org\/10.1091\/mbc.e05-08-0751","journal-title":"Mol Biol Cell"},{"issue":"21","key":"5747_CR20","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1093\/emboj\/cdg545","volume":"22","author":"SS Margolis","year":"2003","unstructured":"Margolis SS, Walsh S, Weiser DC, Yoshida M, Shenolikar S, Kornbluth S (2003) PP1 control of M phase entry exerted through 14\u20133\u20133-regulated Cdc25 dephosphorylation. EMBO J 22(21):5734\u20135745. https:\/\/doi.org\/10.1093\/emboj\/cdg545","journal-title":"EMBO J"},{"issue":"9","key":"5747_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tcb.2005.07.006","volume":"15","author":"H Miki","year":"2005","unstructured":"Miki H, Okada Y, Hirokawa N (2005) Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 15(9):467\u2013476. https:\/\/doi.org\/10.1016\/j.tcb.2005.07.006","journal-title":"Trends Cell Biol"},{"issue":"1","key":"5747_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12565-014-0259-5","volume":"90","author":"S Niwa","year":"2015","unstructured":"Niwa S (2015) Kinesin superfamily proteins and the regulation of microtubule dynamics in morphogenesis. Anat Sci Int 90(1):1\u20136. https:\/\/doi.org\/10.1007\/s12565-014-0259-5","journal-title":"Anat Sci Int"},{"issue":"9","key":"5747_CR23","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/emboj\/cdg208","volume":"22","author":"M Ohsugi","year":"2003","unstructured":"Ohsugi M, Tokai-Nishizumi N, Shiroguchi K, Toyoshima YY, Inoue J, Yamamoto T (2003) Cdc2-mediated phosphorylation of Kid controls its distribution to spindle and chromosomes. EMBO J 22(9):2091\u20132103. https:\/\/doi.org\/10.1093\/emboj\/cdg208","journal-title":"EMBO J"},{"issue":"13","key":"5747_CR24","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1158\/1078-0432.Ccr-04-2551","volume":"11","author":"M Ozen","year":"2005","unstructured":"Ozen M, Ittmann M (2005) Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer. Clin Cancer Res 11(13):4701\u20134706. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-2551","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5747_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4161\/cc.3.6.906","volume":"3","author":"E Perdiguero","year":"2004","unstructured":"Perdiguero E, Nebreda AR (2004) Regulation of Cdc25C activity during the meiotic G2\/M transition. Cell Cycle 3(6):733\u2013737","journal-title":"Cell Cycle"},{"key":"5747_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaq1060","author":"R Pike","year":"2018","unstructured":"Pike R, Ortiz-Zapater E, Lumicisi B, Santis G, Parsons M (2018) KIF22 coordinates CAR and EGFR dynamics to promote cancer cell proliferation. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aaq1060","journal-title":"Sci Signal"},{"issue":"9","key":"5747_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41408-020-00359-2","volume":"10","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV, Kumar S (2020) Multiple myeloma current treatment algorithms. Blood Cancer J 10(9):94. https:\/\/doi.org\/10.1038\/s41408-020-00359-2","journal-title":"Blood Cancer J"},{"issue":"5","key":"5747_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.molcel.2004.11.002","volume":"16","author":"S St Clair","year":"2004","unstructured":"St Clair S, Giono L, Varmeh-Ziaie S, Resnick-Silverman L, Liu WJ, Padi A et al (2004) DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Mol Cell 16(5):725\u2013736. https:\/\/doi.org\/10.1016\/j.molcel.2004.11.002","journal-title":"Mol Cell"},{"issue":"3","key":"5747_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/j.1460-2075.1996.tb00378.x","volume":"15","author":"N Tokai","year":"1996","unstructured":"Tokai N, Fujimoto-Nishiyama A, Toyoshima Y, Yonemura S, Tsukita S, Inoue J et al (1996) Kid, a novel kinesin-like DNA binding protein, is localized to chromosomes and the mitotic spindle. EMBO J 15(3):457\u2013467","journal-title":"EMBO J"},{"issue":"4","key":"5747_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/embo-reports\/kvf069","volume":"3","author":"F Toyoshima-Morimoto","year":"2002","unstructured":"Toyoshima-Morimoto F, Taniguchi E, Nishida E (2002) Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep 3(4):341\u2013348. https:\/\/doi.org\/10.1093\/embo-reports\/kvf069","journal-title":"EMBO Rep"},{"issue":"15","key":"5747_CR31","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","volume":"116","author":"BA Walker","year":"2010","unstructured":"Walker BA, Leone PE, Chiecchio L, Dickens NJ, Jenner MW, Boyd KD et al (2010) A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood 116(15):e56-65. https:\/\/doi.org\/10.1182\/blood-2010-04-279596","journal-title":"Blood"},{"key":"5747_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-4939-0888-2_15","volume":"1170","author":"B Wang","year":"2014","unstructured":"Wang B (2014) Analyzing cell cycle checkpoints in response to ionizing radiation in mammalian cells. Methods Mol Biol 1170:313\u2013320. https:\/\/doi.org\/10.1007\/978-1-4939-0888-2_15","journal-title":"Methods Mol Biol"},{"key":"5747_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1471-2407-14-461","volume":"14","author":"J Wang","year":"2014","unstructured":"Wang J, Ma S, Ma R, Qu X, Liu W, Lv C et al (2014) KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer. BMC Cancer 14:461. https:\/\/doi.org\/10.1186\/1471-2407-14-461","journal-title":"BMC Cancer"},{"issue":"5","key":"5747_CR34","first-page":"4152","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang J, Yu PY, Yu JP, Luo JD, Sun ZQ, Sun F et al (2021) KIF22 promotes progress of esophageal squamous cell carcinoma cells and is negatively regulated by miR-122. Am J Transl Res 13(5):4152\u20134166","journal-title":"Am J Transl Res"},{"key":"5747_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2147\/ott.S152138","volume":"11","author":"H Ying","year":"2018","unstructured":"Ying H, Xu Z, Chen M, Zhou S, Liang X, Cai X (2018) Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins. Onco Targets Ther 11:689\u2013702. https:\/\/doi.org\/10.2147\/ott.S152138","journal-title":"Onco Targets Ther"},{"issue":"6","key":"5747_CR36","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/carcin\/bgu065","volume":"35","author":"Y Yu","year":"2014","unstructured":"Yu Y, Wang XY, Sun L, Wang YL, Wan YF, Li XQ et al (2014) Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression. Carcinogenesis 35(6):1416\u20131425. https:\/\/doi.org\/10.1093\/carcin\/bgu065","journal-title":"Carcinogenesis"},{"issue":"8","key":"5747_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/cm9.0000000000000742","volume":"133","author":"ZY Yu","year":"2020","unstructured":"Yu ZY, Jiang XY, Zhao RR, Qin JJ, Luo CJ, Ren YX et al (2020) Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways. Chin Med J (engl) 133(8):919\u2013928. https:\/\/doi.org\/10.1097\/cm9.0000000000000742","journal-title":"Chin Med J (engl)"},{"issue":"6","key":"5747_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jmcb\/mju045","volume":"6","author":"L Zannini","year":"2014","unstructured":"Zannini L, Delia D, Buscemi G (2014) CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol 6(6):442\u2013457. https:\/\/doi.org\/10.1093\/jmcb\/mju045","journal-title":"J Mol Cell Biol"},{"key":"5747_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6000925","volume":"2022","author":"R Zhang","year":"2022","unstructured":"Zhang R, Ma L, Wei Y, Wei K, Song T, Du Z et al (2022) KIF22 promotes development of pancreatic cancer by regulating the mek\/erk\/p21 signaling axis. Biomed Res Int 2022:1\u201310. https:\/\/doi.org\/10.1155\/2022\/6000925","journal-title":"Biomed Res Int"},{"key":"5747_CR40","doi-asserted-by":"publisher","first-page":"8190","DOI":"10.12659\/MSM.912643","volume":"24","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Xie H, Zhu S, Chen X, Yu J, Shen T et al (2018) High expression of kif22\/kinesin-like dna binding protein (kid) as a poor prognostic factor in prostate cancer patients. Med Sci Monit 24:8190\u20138197","journal-title":"Med Sci Monit"},{"key":"5747_CR41","doi-asserted-by":"publisher","first-page":"12769","DOI":"10.2147\/cmar.S261894","volume":"12","author":"F Zhao","year":"2020","unstructured":"Zhao F, Feng Y, Zhang X, Liu X, Li A (2020) Kinesin superfamily member 18b (kif18b) promotes cell proliferation in colon adenocarcinoma. Cancer Manag Res 12:12769\u201312778. https:\/\/doi.org\/10.2147\/cmar.S261894","journal-title":"Cancer Manag Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05747-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:22:28Z","timestamp":1717989748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05747-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["5747"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05747-w","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors confirm that there were no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the Second Affiliated Hospital of Xi\u2019an Jiaotong University (No. 2015186). All patients gave written informed consent. The animal experiments were approved by the\u00a0Biomedical Ethics Committee  of Xi\u2019an Jiaotong University Health Science Center\u00a0(No. 20221601) and conformed to the principles of laboratory animal welfare and ethics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"239"}}